The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
South East (England); Berkshire, Buckinghamshire and Oxfordshire; Milton Keynes
Location of affected unit(s)
Milton Keynes
Sector
Manufacturing (20 - 21) Manufacture of chemicals and pharmaceuticals 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
100 jobs Number of planned job creations
Announcement Date
25 July 2006
Employment effect (start)
Foreseen end date
Description
A company has employed 100 extra staff to make inhaled insulin dispensers for use in the United States. The controversial inhaled drug Exubera, which treats diabetes, has been approved for use in Europe and the US. Hailed as a breakthrough by Diabetes UK, it has been rejected by the NHS for use in the UK on the grounds of cost.
Medical device manufacturer Bespak said its Milton Keynes factory is now almost exclusively geared towards high volume production of the insulin inhaler. Bespak marketing manager Chris Halling said the company now employed about 200 people at its Milton Keynes factory.
Sources
25 July 2006: BBC Website
Citation
Eurofound (2006), Bespak, Business expansion in United Kingdom, factsheet number 63826, European Restructuring Monitor. Dublin, https://apps.eurofound.europa.eu/restructuring-events/detail/63826.
Eurofound’s ERM restructuring legislation database offers an overview of key restructuring-related regulations in the EU Member States and Norway. Its content is continuously updated to reflect any changes made by national legislators in response to, for instance, policy shifts, legal...
Can Europe still achieve its ambitions for battery manufacturing? To answer this, the article looks at data from Eurofound’s European Restructuring Monitor and explores what recent large-scale restructuring events reveal about the state of play in the EU battery sector.
This working paper offers a comprehensive methodological overview of the European Restructuring Monitor (ERM) databases. Even though the methodology has not changed over time, new categories have been added, and the way it has been used by researchers and policymakers...
This Eurofound research paper explores key trends in restructuring in recent years, highlighting the companies that announced the largest job losses and job gains in the EU. It builds on an analysis of company announcements recorded in Eurofound’s European Restructuring...
In 2023, thousands of workers in big tech lost their jobs. Meta, Amazon, Google, Apple, Microsoft and Salesforce had been considered to offer good and secure jobs up to this point. Giants of the information and communication technology (ICT) sector,...
In 2024, the automotive sector in the EU came to the fore in public and policy discussions. The focus was on the slowdown in electric vehicle (EV) sales, rising global competition, belated investments in new technologies, and the potential closure...